In situ detection of exosomal RNAs for cancer diagnosis
Source abstract
Abstract
Exosomes are considered as biomarkers reflecting the physiological state of the human body. Studies have revealed that the expression levels of specific exosomal RNAs are closely associated with certain cancers. Thus, detection of exosomal RNA offers a new avenue for liquid biopsy of cancers. Many exosomal RNA detection methods based on various principles have been developed, and most of the methods detect the extracted RNAs after lysing exosomes. Besides complex and time-consuming extraction steps, a major drawback of this approach is the degradation of the extracted RNAs in the absence of plasma membrane and cytosol. In addition, there is considerable loss of RNAs during their extraction. In situ detection of exosomal RNAs can avoid these drawbacks, thus allowing higher diagnostic reliability. In this paper, in situ detection of exosomal RNAs was systematically reviewed from the perspectives of detection methods, transport methods of the probe systems, probe structures, signal amplification strategies, and involved functional materials. Furthermore, the limitations and possible improvements of the current in situ detection methods for exosomal RNAs towards the clinical diagnostic application are discussed. This review aims to provide a valuable reference for the development of in situ exosomal RNA detection strategies for non-invasive diagnosis of cancers. STATEMENT OF SIGNIFICANCE: Certain RNAs have been identified as valuable biomarkers for some cancers, and sensitive detection of cancer-related RNAs is expected to achieve better diagnostic efficacy. Currently, the detection of exosomal RNAs is receiving increasing attention due to their high stability and significant concentration differences between patients and healthy individuals. In situ detection of exosomal RNAs has greater diagnostic reliability due to the avoidance of RNA degradation and loss. However, this mode is still limited by some factors such as detection methods, transport methods of the probe systems, probe structures, signal amplification strategies, etc. This review focuses on the progress of in situ detection of exosomal RNAs and aims to promote the development of this field.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Extracellular vesicles in disease · Circular RNAs in diseases · MicroRNA in disease regulation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. A comprehensive review on factors influences biogenesis, functions, therapeutic and clinical implications of exosomes10.2147/IJN.S291956 ↗
2. Exosomes and exosomal RNAs in breast cancer: a status update10.1016/j.ejca.2020.11.033 ↗
3. Engineering exosomes for targeted drug delivery10.7150/thno.52570 ↗
4. Roles of exosomes in diagnosis and treatment of colorectal cancer10.12998/wjcc.v9.i18.4467 ↗
5. The biology, function, and biomedical applications of exosomes10.1126/science.aau6977 ↗
6. Progress in the research of nanomaterial-based exosome bioanalysis and exosome-based nanomaterials tumor therapy10.1016/j.biomaterials.2021.120873 ↗
7. The roles of exosomes in cancer drug resistance and its therapeutic application10.1002/ctm2.257 ↗
8. Exosomes derived from human placental mesenchymal stem cells enhanced the recovery of spinal cord injury by activating endogenous neurogenesis10.1186/s13287-021-02248-2 ↗
9. Exosomes as biomimetic tools for stem cell differentiation: applications in dental pulp tissue regeneration10.1016/j.biomaterials.2016.09.029 ↗
10. Neural stem cell-derived exosomes regulate neural stem cell differentiation through miR-9-Hes1 Axis10.3389/fcell.2021.601600 ↗
11. Isolation and characterization of exosomes for cancer research10.1186/s13045-020-00987-y ↗
12. Exosome-based immunotherapy: a promising approach for cancer treatment10.1186/s12943-020-01278-3 ↗
13. The two faces of exosomes in Parkinson's disease: from pathology to therapy10.1177/1073858421990001 ↗
14. Exosomes as messengers between mother and fetus in pregnancy10.3390/ijms21124264 ↗
15. Exosomal Transfer of miR-185 Is Controlled by hnRNPA2B1 and Impairs Re-endothelialization after vascular injury10.3389/fcell.2021.619444 ↗
16. Microfluidic-based exosome analysis for liquid biopsy10.1002/smtd.202001131 ↗
17. Application of exosomes as liquid biopsy in clinical diagnosis10.1038/s41392-020-00258-9 ↗
18. miR-21 plays a dual role in tumor formation and cytotoxic response in breast tumors10.3390/cancers13040888 ↗
19. Exosomes derived from microRNA-21 overexpressed adipose tissue-derived mesenchymal stem cells alleviate spine osteoporosis in ankylosing spondylitis mice10.1002/term.3304 ↗
20. The role of CASC2 and miR-21 interplay in glioma malignancy and patient outcome10.3390/ijms21217962 ↗
21. MicroRNA-21 as a predictor and prognostic factor for trastuzumab therapy in human epidermal growth factor receptor 2-positive metastatic breast cancer10.1002/jcb.27620 ↗
22. miR-21 promotes non-small cell lung cancer cells growth by regulating fatty acid metabolism10.1186/s12935-019-0941-8 ↗
23. Potential of miR-21 to predict incomplete response to chemoradiotherapy in rectal adenocarcinoma10.3389/fonc.2020.577653 ↗
24. MiR-21 modulates the polarization of macrophages and increases the effects of M2 macrophages on promoting the chemoresistance of ovarian cancer10.1016/j.lfs.2019.117162 ↗
25. Lung cancer cells derived circulating miR-2I promotes differentiation of monocytes into osteoclasts10.2147/OTT.S232876 ↗
26. Nanoparticle-mediated intratumoral inhibition of miR-21 for improved survival in glioblastoma10.1016/j.biomaterials.2019.02.016 ↗
27. Glypican-1 overexpression in different types of breast cancers10.2147/OTT.S315200 ↗
28. A herringbone mixer based microfluidic device (EXO)-E-HB-chip for purifying tumor-derived exosomes and establishing miRNA signature in pancreatic cancer10.1016/j.snb.2021.129511 ↗
29. Recent achievements in exosomal biomarkers detection by nanomaterials-based optical biosensors - a review10.1016/j.aca.2020.02.041 ↗
30. Cubic DNA nanocage-based three-dimensional molecular beacon for accurate detection of exosomal miRNAs in confined spaces10.1016/j.bios.2022.114077 ↗
31. Quantitative and specific detection of exosomal miRNAs for accurate diagnosis of breast cancer using a surface-enhanced Raman scattering sensor based on plasmonic head-flocked gold nanopillars
32. Colorimetric detection of exosomal microRNA through switching the visible-light-induced oxidase mimic activity of acridone derivate10.1016/j.bios.2020.112834 ↗
33. Plasmon-enhanced biosensors for microRNA analysis and cancer diagnosis10.1016/j.bios.2022.114041 ↗
34. Exosomal miR-196b-5p is a potential diagnostic marker for colorectal cancer with metachronous liver metastasis10.21037/tcr.2018.11.09 ↗
35. Detection of multiplex exosomal miRNAs for clinically accurate diagnosis of Alzheimer's disease using label-free plasmonic biosensor based on DNA-Assembled advanced plasmonic architecture10.1016/j.bios.2021.113864 ↗
36. MoS2@Ti3C2 nanohybrid-based photoelectrochemical biosensor: a platform for ultrasensitive detection of cancer biomarker exosomal miRNA10.1016/j.talanta.2021.123077 ↗
37. Enzyme-free electrochemical biosensor based on localized DNA cascade displacement reaction and versatile DNA nanosheets for ultrasensitive detection of exosomal MicroRNA10.1021/acsami.0c14621 ↗
38. Smart design of high-performance surface-enhanced Raman scattering substrates10.1002/smm2.1058 ↗
39. Research advances for exosomal miRNAs detection in biosensing: from the massive study to the individual study10.1016/j.bios.2020.112962 ↗
40. Ultrafast detection of exosomal RNAs via cationic lipoplex nanoparticles in a micromixer biochip for cancer diagnosis10.1021/acsanm.0c03426 ↗
41. DNA nanowire guided-catalyzed hairpin assembly nanoprobe for in situ profiling of circulating extracellular vesicle-associated MicroRNAs10.1021/acssensors.1c02717 ↗
42. Rapid detection of exosomal MicroRNAs using virus-mimicking fusogenic vesicles10.1002/anie.201901997 ↗
43. Biological functions and current advances in isolation and detection strategies for exosome nanovesicles10.1002/smll.201702153 ↗
44. Exosomes: key players in cancer and potential therapeutic strategy10.1038/s41392-020-00261-0 ↗
45. microRNAs biogenesis, functions and role in tumor angiogenesis10.3389/fonc.2020.581007 ↗
46. miRNAs: biogenesis, origin and evolution, functions on virus-host interaction10.1159/000354455 ↗
47. Overview of MicroRNA biogenesis, mechanisms of actions, and circulation10.3389/fendo.2018.00402 ↗
48. MiRNA profiling in pectoral muscle throughout pre- to post-natal stages of chicken development10.3389/fgene.2020.00570 ↗
49. Mortal obligate RNA transcript inhibits cancer cell invasion and migration in lung adenocarcinoma by downregulating miRNA-223
50. miRNA-148a enhances the treatment response of patients with rectal cancer to chemoradiation and promotes apoptosis by directly targeting c-Met10.3390/biomedicines9101371 ↗
51. Therapeutic advances of miRNAs: a preclinical and clinical update10.1016/j.jare.2020.08.012 ↗
52. MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance10.1016/j.mam.2018.07.003 ↗
53. MicroRNA expression profile in extracellular vesicles derived from ALV-J infected chicken semen10.1016/j.virusres.2020.198083 ↗
54. Profiling of primary and mature miRNA expression in atherosclerosis-associated cell types10.1161/ATVBAHA.121.315579 ↗
55. Nanoparticle delivery of miRNA-21 mimic to cardiac macrophages improves myocardial remodeling after myocardial infarction10.1021/acs.nanolett.8b02578 ↗
56. Placental miRNAs in feto-maternal communication mediated by extracellular vesicles10.1016/j.placenta.2020.07.001 ↗
57. miR-21: a non-specific biomarker of all maladies10.1186/s40364-021-00272-1 ↗
58. The origin, function, and diagnostic potential of extracellular microRNAs in human body fluids10.1002/wrna.1208 ↗
59. Gene regulation by long non-coding RNAs and its biological functions10.1038/s41580-020-00315-9 ↗
60. The dharma of nonsense-mediated mRNA decay in mammalian cells10.14348/molcells.2014.2193 ↗
61. Exosomal RNAs: novel potential biomarkers for diseases-a review10.3390/ijms23052461 ↗
62. Emerging role of circular RNAs in cancer10.3389/fonc.2020.00663 ↗
63. Translational control in brain pathologies: biological significance and therapeutic opportunities10.1007/s00401-019-01971-8 ↗
64. Roadblock-qPCR: a simple and inexpensive strategy for targeted measurements of mRNA stability10.1261/rna.076885.120 ↗
65. Ultrasensitive detection of mRNA in extracellular vesicles using DNA tetrahedron-based thermophoretic assay10.1016/j.nantod.2021.101203 ↗
66. PIWI-Interacting RNA: its biogenesis and functions
67. piRNAs as modulators of disease pathogenesis10.3390/ijms22052373 ↗
68. Piwi-interacting RNAs (piRNAs) are dysregulated in renal cell carcinoma and associated with tumor metastasis and cancer-specific survival10.2119/molmed.2014.00203 ↗
69. piRNAs in gastric cancer: a new approach towards translational research10.3390/ijms21062126 ↗
70. Piwi-Interacting RNAs: a new class of regulator in human breast cancer10.3389/fonc.2021.695077 ↗
71. Serum PIWI-Interacting RNAs piR-020619 and piR-020450 are promising novel biomarkers for early detection of colorectal cancer10.1158/1055-9965.EPI-19-1148 ↗
72. Biogenesis and functions of circular RNAs and their role in diseases of the female reproductive system10.1186/s12958-020-00653-5 ↗
73. Diagnostic and prognostic value of circulating CircRNAs in cancer
74. The potential of circular RNAs as cancer biomarkers10.1158/1055-9965.EPI-20-0796 ↗
75. Circular RNAs: the emerging class of non-coding RNAs and their potential role in human neurodegenerative diseases10.1007/s12035-016-0213-8 ↗
76. Circular RNAs in cancer and diabetes10.1007/s12041-021-01268-4 ↗
77. The dysregulation of tRNAs and tRNA derivatives in cancer10.1186/s13046-018-0745-z ↗
78. An emerging role of the 5 ' termini of mature tRNAs in human diseases: current situation and prospects10.1016/j.bbadis.2021.166314 ↗
79. Riddle of the Sphinx: emerging role of transfer RNAs in human cancer10.3389/fphar.2021.794986 ↗
80. A 3 ' tRNA-derived fragment produced by tRNA(LeuAAG) and tRNA(LeuTAG) is associated with poor prognosis in B-cell chronic lymphocytic leukemia, independently of classical prognostic factors10.1111/ejh.13613 ↗
81. CLP1 as a novel player in linking tRNA splicing to neurodegenerative disorders10.1002/wrna.1255 ↗
82. Contribution of upregulated aminoacyl-tRNA biosynthesis to metabolic dysregulation in gastric cancer10.1111/jgh.15592 ↗
83. Alteration of the premature tRNA landscape by gammaherpesvirus infection10.1128/mBio.02664-20 ↗
84. Detection of exosome miRNAs using molecular beacons for diagnosing prostate cancer10.1080/21691401.2018.1489263 ↗
85. Simultaneous and multiplexed detection of exosome microRNAs using molecular beacons10.1016/j.bios.2016.06.058 ↗
86. Simultaneous multiplexed detection of exosomal microRNAs and surface proteins for prostate cancer diagnosis10.1016/j.bios.2019.111749 ↗
87. Visualization and intracellular dynamic tracking of exosomes and exosomal miRNAs using single molecule localization microscopy10.1039/C7NR08800K ↗
88. Exploring the size of DNA functionalized gold nanoparticles for high efficiency exosome uptake and sensitive biosensing10.1016/j.snb.2021.131315 ↗
89. In situ detection of plasma exosomal MicroRNA-1246 for breast cancer diagnostics by a Au nanoflare probe10.1021/acsami.8b12725 ↗
90. Thermophoretic detection of exosomal microRNAs by nanoflares10.1021/jacs.9b13960 ↗
91. DNA nanowire guided-catalyzed hairpin assembly nanoprobe for in situ profiling of circulating extracellular vesicle-associated MicroRNAs10.1021/acssensors.1c02717 ↗
92. High-fidelity determination and tracing of small extracellular vesicle cargoes
93. Spatial confinement-derived double-accelerated DNA cascade reaction for ultrafast and highly sensitive in situ monitoring of exosomal miRNA and exosome tracing10.1021/acs.analchem.1c04916 ↗
94. Rapid exosomes concentration and in situ detection of exosomal microRNA on agarose-based microfluidic chip10.1016/j.snb.2021.129559 ↗
95. In situ single step detection of exosome microRNA using molecular beacon10.1016/j.biomaterials.2015.03.014 ↗
96. Total internal reflection-based single-vesicle in situ quantitative and stoichiometric analysis of tumor-derived exosomal microRNAs for diagnosis and treatment monitoring10.7150/thno.33683 ↗
97. In situ multiplex detection of serum exosomal microRNAs using an all-in-one biosensor for breast cancer diagnosis10.1039/D0AN00393J ↗
98. Analyzing the miRNA content of extracellular vesicles by fluorescence nanoparticle tracking10.1016/j.nano.2016.10.013 ↗
99. Detection of extracellular vesicle RNA using molecular beacons10.1016/j.isci.2019.100782 ↗
100. Accurate cancer diagnosis and stage monitoring enabled by comprehensive profiling of different types of exosomal biomarkers: surface proteins and miRNAs10.1002/smll.202004492 ↗